Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

T Cell Sciences receives grant to develop CETP vaccine

Oct. 4, 1996

Alexion authorized to begin second clinical trial with C5 inhibitor

Oct. 4, 1996

TMR as adjunct to bypass surgery

Oct. 4, 1996

Prodesfarma presents cardiovascular candidate

Oct. 4, 1996

Cardiovascular R&D at Takeda

Sep. 27, 1996

New treatment for peripheral vascular diseases cleared for clinical trials in the U.K.

Sep. 27, 1996

Yamanouchi launches treatment for heart failure

Sep. 27, 1996

Japanese and Korean researchers report improved antiarrhythmic agents

Sep. 27, 1996

Hoechst investigates Na+/H+-exchange inhibitors

Sep. 27, 1996

Hoechst claims new antiarrhythmic agents

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...